Literature DB >> 24743142

A VISTA on PD-1H.

Yang Liu.   

Abstract

Three years ago, two research groups independently identified a previously undescribed T cell cosignaling molecule; one referred to it as V-domain Ig suppressor of T cell activation (VISTA), and the other used the term programmed death-1 homolog (PD-1H). Recombinant and ectopically expressed PD-1H functions as a coinhibitory ligand for T cell responses. However, the function of endogenous PD-1H is not clear. In this issue of the JCI, Flies and colleagues demonstrate that endogenous PD-1H on both T cells and APCs serves as a coinhibitory molecule for T cell activation and provide further support for targeting PD-1H as a therapeutic strategy for transplantation and cancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743142      PMCID: PMC4001562          DOI: 10.1172/JCI75798

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered.

Authors:  M F Bachmann; A Gallimore; E Jones; B Ecabert; H Acha-Orbea; M Kopf
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

Review 2.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

3.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

Authors:  J P Ridge; F Di Rosa; P Matzinger
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

4.  Is CTLA-4 a negative regulator for T-cell activation?

Authors:  Y Liu
Journal:  Immunol Today       Date:  1997-12

5.  Autoimmune disease: immunotherapy by peptides?

Authors:  C A Janeway
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.

Authors:  M F Bachmann; G Köhler; B Ecabert; T W Mak; M Kopf
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

7.  Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity.

Authors:  Dallas B Flies; Xue Han; Tomoe Higuchi; Linghua Zheng; Jingwei Sun; Jessica Jane Ye; Lieping Chen
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

8.  Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.

Authors:  Joel M Kremer; Rene Westhovens; Marc Leon; Eduardo Di Giorgio; Rieke Alten; Serge Steinfeld; Anthony Russell; Maxime Dougados; Paul Emery; Isaac F Nuamah; G Rhys Williams; Jean-Claude Becker; David T Hagerty; Larry W Moreland
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

9.  A fail-safe mechanism for maintaining self-tolerance.

Authors:  S Guerder; P Matzinger
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

10.  Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance.

Authors:  Y Liu; C A Janeway
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  4 in total

1.  VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.

Authors:  Sabrina Ceeraz; Susan K Eszterhas; Petra A Sergent; David A Armstrong; Alix Ashare; Thomas Broughton; Li Wang; Dov Pechenick; Christopher M Burns; Randolph J Noelle; Matthew P Vincenti; Roy A Fava
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

2.  Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability.

Authors:  Qi Wang; Jianwei He; Dallas B Flies; Liqun Luo; Lieping Chen
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

3.  VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.

Authors:  Ming Zhang; Hua-Jin Pang; Wei Zhao; Yu-Fa Li; Li-Xu Yan; Zhong-Yi Dong; Xiao-Feng He
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

4.  Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.

Authors:  Jasneet Kaur Khalsa; Nina Cheng; Joshua Keegan; Ameen Chaudry; Joseph Driver; Wenya Linda Bi; James Lederer; Khalid Shah
Journal:  Nat Commun       Date:  2020-08-06       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.